A retrospective analysis of patient with TNF inhibitor-induced psoriasis also yields consistent findings, indicating that infliximab is the predominant triggering agent, while Crohn's disease and rheumatoid arthritis are the most common primary conditions [229]. The gene discussed is TNF; the disease is psoriasis.